Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bartlmanon May 10, 2019 8:02pm
116 Views
Post# 29736677

RE:RE:How about a buyout by Apple...?

RE:RE:How about a buyout by Apple...?They buy the "company" not just the tech, lock stock and barrel so presumably the company would remain intact but with, likely, much greater access to resources. And, yes, as a matter of fact Apple is moving into healthcare. Another company that I have shares in, Arrayit (otc ARYC) which has an easy-to-use allergy test and sells microarray technology among other things, is a neighbor of and potential business partner with Apple. I got involved with Arrayit 10 years ago when I was looking for a company that had an ovarian cancer test (my wife had just been diagnosed with it - she passed away within 9 months of being diagnosed and there still is no early diagnostic test). At that time, ARYC was promoting their OvaDx test though it was early days. Unfortunately, they spun off that test to another company which has languished. Arrayit is attempting to reacquire the test and may soon be in a position to do so as their revenues seem to be growing significantly.
Bullboard Posts